NIH Guide for the week ending Oct. 1, 2021: funding-related notices and opportunities


National Institutes of Health

UI Contact: 

The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:

General Notices

Notice of Changes to Funding Opportunities

Notices of Intent to Publish

Notices of Special Interest

Funding Opportunities

Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional)
 John E. Fogarty International Center
 National Cancer Institute
 Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
 National Institute of Mental Health
Limited Competition: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)
 Only the current awardee(s) of the Small Cell Lung Cancer (SCLC) Consortium Coordinating Center (U24), funded under PAR-16-050, is/are eligible to apply.
 National Cancer Institute

The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional)
 National Cancer Institute
NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed)
 National Institute on Aging  

NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed)
 National Institute of Neurological Disorders and Stroke
 National Institute on Aging


Role of Astrocytes in Degeneration of the Neurovascular Unit in AD/ADRDs (R01 Clinical Trial Not Allowed)
 National Institute of Neurological Disorders and Stroke
 National Institute on Aging

Systems Biology for Infectious Diseases (U19 Clinical Trial Not Allowed)
 National Institute of Allergy and Infectious Diseases

HEAL initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression Without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development) (UG3/UH3 Clinical Trials Not Allowed)
 National Heart, Lung, and Blood Institute
 National Institute on Alcohol Abuse and Alcoholism
 National Institute on Drug Abuse

Advancing Gender Inclusive Excellence (AGIE) Coordinating Center (U54 Clinical Trial Not Allowed)
 Office of Research on Women's Health
 National Institute of Diabetes and Digestive and Kidney Diseases

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at  or 335-2123, or email Carrie Damon at or Lynn Hudachek at